Advancing Nuclear Medicine
TRP US
Meeting the industry
The Targeted Radiopharmaceuticals (TRP) Summit: an industry-led platform that discusses challenges and opportunities faced by developers of theranostic radio ligand therapies.
This summit will strive to tackle the following topics:
- How do we identify and validate new targets?
- Can we combine targeted radiopharmaceuticals with immunotherapy or other targeted oncology methods?
- How do we improve current clinical design methodologies and patient selection strategies?
- Where can improvements be made to the current supply and fulfillment models?
The TRP US will return in 2024.
About FIELD-LAB
FIELD-LAB is a drug discovery facility that will help you to speed up the development and market launch of new nuclear drugs for cancer treatment. Through supply of small batches of radio chemicals and radio pharmaceuticals, we meet the need of Bio Pharma scientists and start-up ventures for research materials. This will drive both their ambitions to develop a new drug.
- High in demand medical isotope
- Bèta-radiator
- Independent supply by FIELD-LAB
- High Quality
- Chemotherapeutic drug (cisplatin) integrated with Pt-195m by synthesis
- Chemotherapeutic function remains the same
- Single alpha emitting during decay
- Ideal halflife (~10 hour)
- Reliable supply
Practical information
When: July 2024
Where: To be announced.
If you wish to learn more about the speakers, the programme or registration, please check the TRP Summit US website.
Contactform
We look forward to meet you!
If you want to get in touch about the TRP Summit US or want to learn more about FIELD-LAB and Advancing Nuclear Medicine, please leave your contact information in this form. We will reach out to you as soon as possible.